Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anja Tiede

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Metabolic Brain Disease|December 10, 2024
Value of systemic inflammation markers for the detection of minimal and prediction of overt hepatic encephalopathy after TIPS insertionAnja Tiede, Lena Stockhoff, Alena F Ehrenbauer, et al.
JHEP Reports : Innovation in Hepatology|March 24, 2025
Decreasing interleukin-6 levels after TIPS predict outcomes in decompensated cirrhosisAndrea Kornfehl, Anja Tiede, Paul Hemetsberger, et al.
Clinical and Molecular Hepatology|November 21, 2024
Insertion of a transjugular intrahepatic portosystemic shunt leads to sustained reversal of systemic inflammation in patients with decompensated liver cirrhosisAnja Tiede, Lena Stockhoff, Zhaoli Liu, et al.
Gut Microbes|April 21, 2025
Distinct clusters of bacterial and fungal microbiota in end-stage liver cirrhosis correlate with antibiotic treatment, intestinal barrier impairment, and systemic inflammationLaura Buttler, David A Velázquez-Ramírez, Anja Tiede, et al.
Alimentary Pharmacology & Therapeutics|August 28, 2024
No value of non-selective beta-blockers after TIPS-insertionAnja Tiede, Lena Stockhoff, Hannah Rieland, et al.
Medcomm|November 7, 2025
Neurofilament Light Chains in Serum Predict Post-Transjugular Intrahepatic Portosystemic Shunt Hepatic EncephalopathyChristian Labenz, Eva Maria Schleicher, Myriam Meineck, et al.
JHEP Reports : Innovation in Hepatology|June 17, 2025
Minimal residual ascites 3 months after TIPS implantation implicates worse clinical outcomes in patients with cirrhosisJim Benjamin Mauz, Lukas Hartl, Andrea Kornfehl, et al.
Alimentary Pharmacology & Therapeutics|August 2, 2025
Impact of Frailty on the Prognosis of Patients With Liver Cirrhosis Undergoing Insertion of a TIPSMartin Andreas Kabelitz, Simon Johannes Gairing, Anja Tiede, et al.
Hepatology (Baltimore, Md.)|January 8, 2025
Identification of optimal portal pressure decrease to control ascites while minimizing HE after TIPS: A multicenter studyMartin A Kabelitz, Lukas Hartl, Golda Schaub, et al.
Journal of Hepatology|February 6, 2025
Freiburg index of post-TIPS survival (FIPS) identifies patients at risk of further decompensation and ACLF after TIPSLukas Sturm, Michael Schultheiss, Fabian Stöhr, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Metabolic Brain Disease|December 10, 2024
Value of systemic inflammation markers for the detection of minimal and prediction of overt hepatic encephalopathy after TIPS insertionAnja Tiede, Lena Stockhoff, Alena F Ehrenbauer, et al.
JHEP Reports : Innovation in Hepatology|March 24, 2025
Decreasing interleukin-6 levels after TIPS predict outcomes in decompensated cirrhosisAndrea Kornfehl, Anja Tiede, Paul Hemetsberger, et al.
Clinical and Molecular Hepatology|November 21, 2024
Insertion of a transjugular intrahepatic portosystemic shunt leads to sustained reversal of systemic inflammation in patients with decompensated liver cirrhosisAnja Tiede, Lena Stockhoff, Zhaoli Liu, et al.
Gut Microbes|April 21, 2025
Distinct clusters of bacterial and fungal microbiota in end-stage liver cirrhosis correlate with antibiotic treatment, intestinal barrier impairment, and systemic inflammationLaura Buttler, David A Velázquez-Ramírez, Anja Tiede, et al.
Alimentary Pharmacology & Therapeutics|August 28, 2024
No value of non-selective beta-blockers after TIPS-insertionAnja Tiede, Lena Stockhoff, Hannah Rieland, et al.
Medcomm|November 7, 2025
Neurofilament Light Chains in Serum Predict Post-Transjugular Intrahepatic Portosystemic Shunt Hepatic EncephalopathyChristian Labenz, Eva Maria Schleicher, Myriam Meineck, et al.
JHEP Reports : Innovation in Hepatology|June 17, 2025
Minimal residual ascites 3 months after TIPS implantation implicates worse clinical outcomes in patients with cirrhosisJim Benjamin Mauz, Lukas Hartl, Andrea Kornfehl, et al.
Alimentary Pharmacology & Therapeutics|August 2, 2025
Impact of Frailty on the Prognosis of Patients With Liver Cirrhosis Undergoing Insertion of a TIPSMartin Andreas Kabelitz, Simon Johannes Gairing, Anja Tiede, et al.
Hepatology (Baltimore, Md.)|January 8, 2025
Identification of optimal portal pressure decrease to control ascites while minimizing HE after TIPS: A multicenter studyMartin A Kabelitz, Lukas Hartl, Golda Schaub, et al.
Journal of Hepatology|February 6, 2025
Freiburg index of post-TIPS survival (FIPS) identifies patients at risk of further decompensation and ACLF after TIPSLukas Sturm, Michael Schultheiss, Fabian Stöhr, et al.
Pageof 2